BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 24609929)

  • 1. The EANM clinical and technical guidelines for lymphoscintigraphy and sentinel node localization in gynaecological cancers.
    Giammarile F; Bozkurt MF; Cibula D; Pahisa J; Oyen WJ; Paredes P; Olmos RV; Sicart SV
    Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1463-77. PubMed ID: 24609929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer.
    Giammarile F; Alazraki N; Aarsvold JN; Audisio RA; Glass E; Grant SF; Kunikowska J; Leidenius M; Moncayo VM; Uren RF; Oyen WJ; Valdés Olmos RA; Vidal Sicart S
    Eur J Nucl Med Mol Imaging; 2013 Dec; 40(12):1932-47. PubMed ID: 24085499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma.
    Bluemel C; Herrmann K; Giammarile F; Nieweg OE; Dubreuil J; Testori A; Audisio RA; Zoras O; Lassmann M; Chakera AH; Uren R; Chondrogiannis S; Colletti PM; Rubello D
    Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1750-1766. PubMed ID: 26205952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The EANM practical guidelines for sentinel lymph node localisation in oral cavity squamous cell carcinoma.
    Giammarile F; Schilling C; Gnanasegaran G; Bal C; Oyen WJG; Rubello D; Schwarz T; Tartaglione G; Miller RN; Paez D; van Leeuwen FWB; Valdés Olmos RA; McGurk M; Delgado Bolton RC
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):623-637. PubMed ID: 30564849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EANM-EORTC general recommendations for sentinel node diagnostics in melanoma.
    Chakera AH; Hesse B; Burak Z; Ballinger JR; Britten A; Caracò C; Cochran AJ; Cook MG; Drzewiecki KT; Essner R; Even-Sapir E; Eggermont AM; Stopar TG; Ingvar C; Mihm MC; McCarthy SW; Mozzillo N; Nieweg OE; Scolyer RA; Starz H; Thompson JF; Trifirò G; Viale G; Vidal-Sicart S; Uren R; Waddington W; Chiti A; Spatz A; Testori A;
    Eur J Nucl Med Mol Imaging; 2009 Oct; 36(10):1713-42. PubMed ID: 19714329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comment on: the EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer.
    Aprile C; Buroni FE; Lodola L; Persico MG
    Eur J Nucl Med Mol Imaging; 2014 Jun; 41(6):1257-8. PubMed ID: 24668275
    [No Abstract]   [Full Text] [Related]  

  • 7. Response to comment by Aprile et al.: the EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer.
    Giammarile F; Alazraki N; Aarsvold JN; Audisio RA; Glass E; Grant SF; Kunikowska J; Leidenius M; Moncayo VM; Uren RF; Oyen WJ; Olmos RA; Sicart SV
    Eur J Nucl Med Mol Imaging; 2014 Jun; 41(6):1259-60. PubMed ID: 24668277
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical significance of the lymphoscintigraphy in the evaluation of non-axillary sentinel lymph node localization in breast cancer.
    Gherghe M; Bordea C; Blidaru A
    Chirurgia (Bucur); 2015; 110(1):26-32. PubMed ID: 25800312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SNMMI Procedure Standard/EANM Practice Guideline on Pediatric
    Vali R; Alessio A; Balza R; Borgwardt L; Bar-Sever Z; Czachowski M; Jehanno N; Kurch L; Pandit-Taskar N; Parisi M; Piccardo A; Seghers V; Shulkin BL; Zucchetta P; Lim R
    J Nucl Med; 2021 Jan; 62(1):99-110. PubMed ID: 33334912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on new imaging technologies in sentinel node detection.
    Pelligra S; Scaletta G; Cianci S; Gueli Alletti S; Restaino S; Fagotti A; Scambia G; Fanfani F
    Minerva Ginecol; 2020 Dec; 72(6):404-412. PubMed ID: 33306284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph nodes in gynaecological malignancies: frontline between TNM and clinical staging systems?
    Zámbó K; Koppán M; Paál A; Schmidt E; Tinneberg HR; Bódis J
    Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1684-8. PubMed ID: 13680196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current application of sentinel lymph node lymphoscintigraphy to detect various cancer metastases.
    Hubalewska-Dydejczyk A; Sowa-Staszczak A; Huszno B
    Hell J Nucl Med; 2006; 9(1):5-9. PubMed ID: 16617387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node sampling in gynaecological cancers: techniques and clinical applications.
    El-Ghobashy AE; Saidi SA
    Eur J Surg Oncol; 2009 Jul; 35(7):675-85. PubMed ID: 18980825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of Radiation Exposure of Non-Dominant Index for the Surgeon Performing Sentinel Lymph-Node Removal Procedure.
    Peştean C; Larg MI; Bărbuş E; Bădulescu C; Piciu D
    Curr Radiopharm; 2018; 11(1):64-68. PubMed ID: 29412126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversies in Sentinel Lymph Node Biopsy for Gynecologic Malignancies.
    Rossi EC; Tanner E
    J Minim Invasive Gynecol; 2021 Mar; 28(3):409-417. PubMed ID: 33359741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic mapping and sentinel node biopsy in endometrial cancer--a feasibility study using cervical injection of radiotracer and blue dye.
    Kadkhodayan S; Shiravani Z; Hasanzadeh M; Sharifi N; Yousefi Z; Fattahi A; Sadeghi R
    Nucl Med Rev Cent East Eur; 2014; 17(2):55-8. PubMed ID: 25088102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contribution of nuclear medicine to lymphatic mapping and sentinel node identification in oncology].
    Valdés Olmos RA; Jansen L; Muller SH; Hoefnagel CA; Nieweg O
    Rev Esp Med Nucl; 1999; 18(2):111-21. PubMed ID: 10352326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lymph node mapping and sentinel node detection in gynecological oncology].
    Pityński K; Basta A
    Ginekol Pol; 2002 Nov; 73(11):1159-64. PubMed ID: 12722417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
    Tsugawa K; Noguchi M; Miwa K; Bando E; Yokoyama K; Nakajima K; Michigishi T; Tonami N; Minato H; Nonomura A
    Breast Cancer; 2000 Jan; 7(1):87-94. PubMed ID: 11029778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel Node Mapping in Gynecologic Cancers: A Comprehensive Review.
    Skanjeti A; Dhomps A; Paschetta C; Tordo J; Giammarile F
    Semin Nucl Med; 2019 Nov; 49(6):521-533. PubMed ID: 31630736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.